News

Astrazeneca’s Coronavirus Vaccine Shows Positive Results

Astrazeneca’s Coronavirus Vaccine Shows Positive Results

Astrazeneca’s coronavirus vaccine shows promise in an early phase clinical trial. The phase one trial involved over 1,000 participants aged 18-55, with reported side effects mild overall. With a comprehensive customer portal perfect for large scale trials, Yourway allows our clients to manage the movement of goods, monitoring critical factors like location, temperature, shock and vibration, and exposure to light, all crucial to maintaining quality in a successful clinical trial.

Back to Index
Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Media

Articles

The New Normal in Clinical Trial Protection

Open chat
Come chat with us!
Hello! How can I help you?